Steven Ringel 5/21/26 Steven Ringel 5/21/26

ASGCT 2026 Recap: How Personalized Gene Therapies Are Becoming Real for Rare Disease Families

Read More

Steven Ringel 5/5/26 Steven Ringel 5/5/26

How AI Can Cut the Cost of Personalized Gene Therapy

Read More

Steven Ringel 4/21/26 Steven Ringel 4/21/26

Who Owns the Cure? The Case for Patient Control in Rare Disease Drug Development

Read More

Steven Ringel 4/12/26 Steven Ringel 4/12/26

N-of-1 Therapy Explained: What are the steps and timelines?

Read More

Steven Ringel 4/12/26 Steven Ringel 4/12/26

The New York Times Wrote About Rare Disease Gene Therapy. Here Is What They Left Out

Read More

Steven Ringel 4/12/26 Steven Ringel 4/12/26

Patient-Derived Cells: The Essential Foundation for Personalized Drug Development.

Read More

Steven Ringel 4/12/26 Steven Ringel 4/12/26

Landscape Review: The State of Gene Therapy and ASO Development

Read More

Steven Ringel 4/12/26 Steven Ringel 4/12/26

Gene Replacement vs. Gene Editing: Are they the same thing?

Read More